| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |